Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

102 results about "Avascular necrosis" patented technology

Death of bone tissue due to temporary or permanent loss of blood supply to the bones.

System and Method of Up-Regulating Bone Morphogenetic Proteins (Bmp) Gene Expression in Bone Cells Via the Application of Fields Generated by Specific and Selective Electric and Electromagnetic Signals

InactiveUS20070299472A1High expressionBiocideElectrotherapyHuman DNA sequencingBone Morphogenetic Protein Gene
Methods and devices are described for the regulation of bone morphogenetic protein gene expression in bone cells via the application of fields generated by specific and selective electric and electromagnetic signals in the treatment of diseased or injured bone. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased bone tissue that include generating specific and selective electric and electromagnetic signals that generate fields optimized for increase of bone morphogenetic protein gene expression and exposing bone to the fields generated by specific and selective signals so as to regulate bone morphogenetic protein gene expression in such bone tissue. The resulting methods and devices are useful for the targeted treatment of bone fractures, fractures at risk, delayed unions, nonunion of fractures, bone defects, spine fusions, osteonecrosis or avascular necrosis, as an adjunct to other therapies in the treatment of one or all of the above, and in the treatment of osteoporosis.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Ankle prosthesis and method for implanting ankle prosthesis

ActiveUS20050192673A1Ankle jointsJoint implantsAnkle joint replacementGrowth plate arrest
One embodiment of the present invention relates to an ankle prosthesis. Another embodiment of the present invention relates to a total ankle replacement prosthesis. Another embodiment of the present invention relates to an ankle replacement (partial or total) which is adapted, for example: (a) to treat arthritis of the ankle (e.g., ankle arthritis of any cause: after precious trauma; primary; malalignment induced; after hindfoot fusion; from recurrent ankle instability; rheumatoid or inflammatory arthritis; gout; local growth; dysplasia; growth plate arrest; avascular necrosis; hemophilia; distant septic event); (b) to revise a fused ankle; and / or (c) to treat trauma. The ankle replacement may be carried out by replacing one or more joint surfaces of an ankle joint. Another embodiment of the present invention relates to a method for inserting an ankle prosthesis.
Owner:UNIV OF IOWA RES FOUND

Implant depots to deliver growth factors to treat avascular necrosis

ActiveUS20070259018A1Treat and alleviate AVN bone problemIncreasing bone mineral densityPeptide/protein ingredientsAntipyreticPorosityBone structure
The present invention relates to the design and composition of a depot implant for optimal delivery of growth factors to treat bone avascular necrosis, in that such depot implant is constructed to be in a cylinder (rod) or sphere shape and have a natural or synthetic polymer scaffold with or without impregnated calcium phosphate particles. The density of the depot is higher than a typical BMP sponge carrier to facilitate it's implantation and slower release of the growth factor. The scaffold is such that it has adequate porosity and pore size to facilitate growth factor seeding and diffusion throughout the whole of the bone structure resulting in increased new blood vessel growth and density in the avascular necrotic bone. In addition, the shape of the depot implant allows for delivery through a cannula or large bore needle.
Owner:WARSAW ORTHOPEDIC INC

Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields

Methods and devices are described for the regulation of Transforming Growth actor (TGF)-β1, β2, and / or β3 protein gene expression in bone cells and other tissues via the capacitive coupling or inductive coupling of specific and selective electric fields to the bone cells or other tissues, where the specific and selective electric fields are generated by application of specific and selective electric and electromagnetic signals to electrodes or one or more coils or other field generating device disposed with respect to the bone cells or other tissues so as to facilitate the treatment of diseased or injured bone and other tissues. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased bone and other tissue that include generating specific and selective electric and electromagnetic signals that generate fields in the target tissue optimized for increase of TGF-β1, β2, and / or β3 protein gene expression and exposing bone and other tissue to the fields generated by specific and selective signals so as to regulate TGF-β1, β2, and / or β3 protein gene expression in such tissue. The resulting methods and devices are useful for the targeted treatment of bone fractures, fractures at risk, delayed unions, nonunion of fractures, bone defects, spine fusions, osteonecrosis or avascular necrosis, as an adjunct to other therapies in the treatment of one or all of the above, in the treatment of osteoporosis, and in other conditions in which TGF-β1, β2, and / or β3 protein may be implicated.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Modular Femoral Head Surface Replacement, Modular Femoral Neck Stem, and Related Sleeve, Adapter, and Osteoconducting Rod

Disclosed therein is a big femoral head and femoral head surface replacement, which are used for hip osteoarthritis and vascular necrosis of femoral head. As a person get older and aged, the weight bearing hip joint is indispensably changed to osteoarthritis and sometimes showed avascular necrosis of the femoral head with unknown etiology. The deformed femoral head and hip joint should be replaced with the THA. Till now, the total hip replacement is performed in such a way that the necrosed femoral head and a healthy femoral neck are all removed and a femoral stem is inserted into the marrow cavity, and in this case, a small femoral head causes a reduction of a range of motion and dislocation of the hip joint occasionally, and osteolysis due to abrasion of plastic acetabular liner. In case of a conventional femoral head surface replacement (hereinafter, called “conventional FHSR”), a complication of femoral neck fracture and could not combined use with conventional THA. Recently, hard bearing system such as metal on metal THA or ceramic on ceramic THA without using plastic has been introduced to solve the problem of osteolysis due to abraded plastic particles generated when the THA is worn out as time goes. But there also have many problems as a limited range of motion, resected normal femoral neck and difficulties of rereplacement of the femoral stem. Because of the big femoral head or the FHSR can increase the range of motion and lower dislocation rate these devices are gradually widespread in young active person and Asian peoples. This invented design of the modularity gives the convenience to the surgeon and economically lower burden to patients to use of the FHSR and big femoral head system. The related accessory showed initial stability of the FHSR during operation and prevent from femoral neck fracture in follow-up periods.
Owner:PARK HYUNG BAE

Methods of treatment using an EP2 selective receptor agonist

The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.
Owner:PFIZER INC

Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields

Methods and devices are described for the regulation of Transforming Growth actor (TGF)-β1, β2, and / or β3 protein gene expression in bone cells and other tissues via the capacitive coupling or inductive coupling of specific and selective electric fields to the bone cells or other tissues, where the specific and selective electric fields are generated by application of specific and selective electric and electromagnetic signals to electrodes or one or more coils or other field generating device disposed with respect to the bone cells or other tissues so as to facilitate the treatment of diseased or injured bone and other tissues. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased bone and other tissue that include generating specific and selective electric and electromagnetic signals that generate fields in the target tissue optimized for increase of TGF-β1, β2, and / or β3 protein gene expression and exposing bone and other tissue to the fields generated by specific and selective signals so as to regulate TGF-β1, β2, and / or β3 protein gene expression in such tissue. The resulting methods and devices are useful for the targeted treatment of bone fractures, fractures at risk, delayed unions, nonunion of fractures, bone defects, spine fusions, osteonecrosis or avascular necrosis, as an adjunct to other therapies in the treatment of one or all of the above, in the treatment of osteoporosis, and in other conditions in which TGF-β1, β2, and / or β3 protein may be implicated
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Method and composition for treating osteonecrosis and/or avascular necrosis

By providing an elastic form stable material which is capable of being delivered directly to a specific desired location within a living creature and provides increased strength and rigidity to the injected location, disorders of the trabecular bone or subchondral tissue of a living creature are able to be effectively treated. Treatment of necrosis of the bone beneath the cartilage in skeletal joints and other defects in bony or cartilaginous structures is achieved with a variation of the subject material specific to each application. In the preferred method, the elastic form stable material is injected directly into the affected area, thereby achieving the desired result.
Owner:BONWRX INC

Open loop type circumcision device

The present invention relates to a prepuce cutting device, which solves the technical problem of the defect of the prior prepuce cutting device which can not expand along with the prepuce erection. The present invention provides an open-loop prepuce cutting device which comprises a cutting ring and a bandage; the external circumference of the cutting ring is provided with an annular groove and the bandage can bind the prepuce in the annular groove; the cutting ring with certain flexibility is provided with a fracture; the bandage can be a retractable flexible bandage and the flexible bandage can select sterilized and disinfected nylon line, suture, flexible rubber ring, etc., so the abundant prepuce of the patient is bound on the cutting ring and the partial prepuce naturally falls off due to avascular necrosis. As the cutting device is the open-loop design, the internal diameter can be automatically adjusted, and when the prepuce erects, the ring can expand, and when the penis weakens, the ring can synchronously shrink, thus greatly reducing the patient pain. The present invention with the advantages of simple structure, convenient use, low cost and less pain is applied in the prepuce cutting operation.
Owner:谭晓雯 +1

Urine-leakage-prevention and blockage-prevention catheter

The invention discloses a urine-leakage-prevention and blockage-prevention catheter, which comprises a catheter body and a guide wire, wherein the center of the catheter body is a urine discharging passage; the front section of the catheter body is provided with a self-expansion opening section; the front end of the self-expansion opening section is provided with a cap-shaped front blind end; the middle section of the catheter body is provided with a urine-leakage-prevention air bag; an anti-sliding air bag is arranged between the urine-leakage-prevention air bag and the self-expansion opening section; the urine-leakage-prevention air bag and the anti-sliding air bag are connected to a multi-passage air bag inflating connector arranged at the back section of the catheter body through an inflating passage; the self-expansion opening section is connected with a flushing and medication connector arranged at the back section of the catheter body through a flushing and medication integral passage; the back end of the catheter body is a drainage outlet; and the drainage outlet is provided with an opening sealing cap. The urine-leakage-prevention and blockage-prevention catheter has the advantages that the complete blockage probability of the catheter caliber part is reduced; the injury on the human body is reduced; the retention of harmful urine in the bladder is reduced; and the mucomembranous avascular necrosis injury due to long-time compression of the urethra inner wall tissue by the air bag in the same position is avoided.
Owner:AFFILIATED HOSPITAL OF JIANGSU UNIV

Expression method of Beclin1 and MAP1-LC3 (microtubule-associated protein 1-light chain 3) in steroid-induced avascular necrosis of femoral head of rabbit

InactiveCN103675251ACan regulate autophagic activitySimple methodDisease diagnosisBiological testingRight femoral headMicrotubule-Associated Protein 1 Light Chain 3
The invention discloses an expression method of Beclin1 and MAP1-LC3 (microtubule-associated protein 1-light chain 3) in steroid-induced avascular necrosis of femoral head of a rabbit, detection of a bone cell apoptosis index of a femoral head tissue of a rabbit SANFH (steroid-induced avascular necrosis of femoral head) model and the MAP1-LC3 expression shows that autophagy-related gene Beclin1 can regulate autophagy activity and also can selectively combine with family members of Bcl-2 (B-cell lymphoma-2) to regulate the cell apoptosis activity. By detection of the expression of the Beclin1 in the SANFH model, the expression method provides a new molecular target for treatment of SANFH. The expression method is simple and convenient in operation, better solves the problem that no study on cell apoptosis and autophagy expression and mutual relation thereof in the SANFH model is found at home and abroad, and fills the blank of the study on cell apoptosis and autophagy expression and the mutual relation thereof in an ANFH (avascular necrosis of femoral head) model.
Owner:刘万林

Pin guide for operating on avascular necrosis of the femoral head

A pin guide for the surgical operation of an avascular necrosis of a femoral head includes a guide body having a central pin guide hole extending along a centerline of the guide body and a plurality of side pin guide holes formed so as to make a specified angle with the central pin guide hole. The side pin guide holes are radially arranged around the central pin guide hole at a front side of the guide body and joined to the central pin guide hole at a rear side of the guide body.
Owner:THE CATHOLIC UNIV OF KOREA IND ACADEMIC COOPERATION FOUND

Comfortable-to-use irritation-reduction trachea cannula

The invention discloses a comfortable-to-use irritation-reduction trachea cannula, which comprises a main cannula, fixed sleeve bags, a lower absorption sleeve, an air injection tube and a lower absorption tube, wherein the appearance of the main cannula simulates the structure of the respiratory tract; the main cannula is made of flexible materials; at least two fixed sleeve bags are arranged on the main cannula; all of the fixed sleeve bags are communicated; the fixed sleeve bags are connected with the air injection tube; the insertion end of the main insertion tube is provided with the lower absorption sleeve; and the lower absorption sleeve is connected with the lower absorption tube. The comfortable-to-use irritation-reduction trachea cannula has the advantages that the irritation on the trachea is small; and the conditions of tracheal mucosa avascular necrosis and cough cannot easily occur; the insertion end of the main cannula is provided with the lower absorption sleeve; secreta generated on the trachea inner wall near an air flow hole can be absorbed and can be discharged out of the body through the lower absorption tube; secreta in the respiratory tract can be continuously cleared; and the occurrence of the catheter blockage condition is avoided.
Owner:QIANFOSHAN HOSPITAL OF SHANDONG

Use of EP2 selective receptor agonists in medical treatment

The present invention relates to methods of treating pulmonary hypertension, facilitating joint fusion, facilitating tendon and ligament repair, reducing the occurrence of secondary fracture, treating avascular necrosis, facilitating cartilage repair, facilitating bone healing after limb transplantation, facilitating liver regeneration, facilitating wound healing, reducing the occurrence of gastric ulceration, treating hypertension, facilitating the growth of tooth enamel or finger or toe nails, treating glaucoma, treating ocular hypertension, and repairing damage caused by metastatic bone disease using an EP2 selective receptor agonist.
Owner:PFIZER PRODS ETAT DE CONNECTICUT

Circumcision device

InactiveCN102217970AUse Performance AdvantageOvercome the defect that the diameter cannot be changedSurgeryForeskinAvascular necrosis bone
The invention relates to a circumcision device, which belongs to the field of medical instruments. The circumcision device comprises a supporting structure and a blocking structure, wherein the supporting structure and the blocking structure are matched together to finish circumcision. The circumcision device ensures that foreskin tissues to be removed generate avascular necrosis and fall off by blocking off blood supply, so a complete and smooth excision surface can be formed without bleeding and with little pain.
Owner:范勤

Experimental method of effects of DNA oxidative damage and bone cell apoptosis on avascular necrosis

The invention discloses an experimental method of effects of DNA oxidative damage and bone cell apoptosis on avascular necrosis, the method comprises the following steps: experimental grouping and establishment of an animal model, preparation of specimens, histomorphology observation under a light microscope, observation by a transmission electron microscope, bone cell apoptosis situation detection by TUNEL (terminal dexynucleotidyl transferase(TdT)-mediated dUTP nick end labeling) method, bone marrow hematopoietic cell DNA oxidative damage detection by monoclonal antibody N45.1 immunohistochemistry method, and statistical analysis. According to the method, experiment animals are respectively killed in the second week and the fourth week after the last time of administration, and five animals are killed for each time in each group; bilateral femoral heads are taken for conventional fixed decalcification for stand-by testing, the number of vacant bone lacunas is counted by HE (hematoxylin-eosin) staining, the bone cell morphological change is observed by the electron microscope, the bone cell apoptosis situation is detected by the TUNEL method, the bone marrow hematopoietic cell DNA oxidative damage is detected by the immunohistochemistry method, and the relationship between SANFH ((steroid-induced avascular necrosis of femoral head)) and the bone marrow hematopoietic cell DNA oxidative damage and the bone cell apoptosis is explored, and provides new ideas for the further study of pathogenesis of the steroid induced avascular necrosis of femoral head.
Owner:刘万林

Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions

A method for the treatment and / or prophylaxis of an osteonecrotic bone disease in a mammal in need thereof, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia / osteonecrosis, Legg-Calve-Perthes disease and femoral head necrosis, the method comprising administering an effective dose of a strontium-containing compound (a) to the mammal. A method for the treatment and / or prophylaxis of an osteonecrotic bone disease, such as, e.g., idiopathic or secondary osteonecrosis, avascular hone necrosis, glucocorticoid induced bone ischemia / osteonecrosis and femoral head necrosis, in a mammal who is to be or is treated with a therapeutic agent (b) known to or suspected of inducing apoptosis and / or necrosis of bone cells, the method comprising administering a strontium-containing compound (a) in combination with (b).
Owner:OSTEOLOGIX AS

Umbrella shaped memory alloy support in femoral head

An umbrella shaped memory alloy support in femoral head comprises an umbrella shaped support and a support sleeve, wherein the lower end of the umbrella shaped support is in sleeve joint with the support sleeve by an umbrella handle; the umbrella shaped support is formed by eight supporting ribs; the support sleeve is formed by rolling plates; blood supply holes are distributed on the wall of the support sleeve; and withdrawal preventing pawls are arranged on the outer surface of the support sleeve. The support not only plays a powerful supporting role in femoral head, but also can assist in revascularization of femoral head, prevent further collapse of femoral head, alleviate more pains of the patients, shorten the operation time and simplify the operation, is safe and reliable in supporting and has obvious effect on treating collapse of femoral head caused by adult avascular necrosis of femoral head. The support has simple process and shape, is easy to deform and insert, is stable in installation after complex, is convenient to use in operation and is secure and reliable in fixation.
Owner:LANZHOU SEEMINE SMA CO LTD

Foot, ankle and lower extremity compression and fixation system and related uses

ActiveUS9308025B2FractureExternal osteosynthesisAnkle joint operationsFibrous union
In general, various embodiments of the present invention comprise an external fixation device, an internal fixation device, and a lower extremity stabilizer. The external fixation device is connected to the lower extremity stabilizer and the external fixation device is adjustably connected to the internal fixation device. The internal fixation device is capable of being attached to at least one bone in a patient's foot, ankle, and / or lower extremity. The system is capable of simultaneously compressing and stabilizing at least one bone for treating Charcot neuroarthropathy, fractures, revisional foot and ankle surgery including but not limited to malunions, nonunions, delayed unions, fibrous unions, avascular necrosis, resected osteomyelitis, incorporated autogenous and / or allogenic bone grafts for arthrodesis procedures, pseudoarthrosis and bones with decreased mineral density and cortical stiffness, and / or the like for any reconstructive and / or elective foot and ankle surgery where a compression arthrodesis is needed. The external fixation device and / or lower extremity stabilizer can be removed after a certain period of time, leaving the internal fixation system within the body for prolonged stabilization and maintenance of the arthrodesis site(s).
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST

Method and apparatus for monitoring blood flow to the hip joint

Devices, systems and methods for performing arthroscopic evaluations and procedures in and near the hip joint are provided. An arthroscopic probe having a Doppler probe disposed on a movable tip portion is useful for determining blood flow and for identifying vascular structures. An arthroscopic probe having a Doppler probe and a radiofrequency (RF) source disposed on a movable tip portion provides further useful features including the ability to perform cauterization, tissue ablation, and other RF procedures. The devices, systems, and methods are effective to assist an operating surgeon in the assessment of femoral head blood supply before, during, and after procedures involving the hip joint and optionally to provide for RF procedures in concert with such assessments of blood flow. The devices, systems, and methods of the present invention aid in arthroscopic procedures, and are useful in reducing the risk of iatrogenic hip joint avascular necrosis (AVN).
Owner:PHILIPPON MARC +1

Combined stent

ActiveCN106798600APromotes regenerative repairRestoration of biomechanical strengthFemur3D printingRight femoral headInsertion stent
The invention relates to the field of medical instruments and provides a combined stent. The combined stent comprises a bone support (1), a proximal connector (2) and a distal connector (3), and pore channels (12) are formed in the bone support (1); the proximal connector (2) is connected to the tail of the bone support (1), and pore channels (12) are formed in the proximal connector (2); the distal connector (3) is connected to the tail of the proximal connector (2), pore channels (12) are formed in the distal connector (3), and after the bone support (1), the proximal connector (2) and the distal connector (3) form the stent by connection, the pore channels (12) therein are communication with one another. The combined stent can realize treatment of avascular necrosis of the femoral head by means of combined transplantation of blood vessels.
Owner:BEIJING SHAPEDREAM INFORMATION TECH CO LTD

Traditional Chinese medicine compound for curing glucoticorticoid-induced avascular necrosis of the femoral head

ActiveCN101919948ASolve the problem of increased internal pressureNecrotic symptoms are goodSkeletal disorderUnknown materialsRight femoral headTarsal Joint
The invention relates to a traditional Chinese medicine compound for curing glucoticorticoid-induced avascular necrosis of the femoral head (SANFH) and aims at the problem of the SANFH that the obstacle of blood circulation causes the caput femoris ischaemia and the caput femoris vein backflow obstruction causes the increasing of the inner pressure of the caput femoris. The compound is prepared by using medicines which tonify Qi and blood, promote blood circulation, remove obstruction in channels, eliminate the blood stasis, enrich kidney essence and lubricate joint. The medicines particularly contain Astragalus mongholicus, the root of red-rooted salvia, fructus psoraleae, rhizoma alismatis, the root of bidentate achyranthes, fleece-flower root, tortoise plastron and daemonorops draco. The medicine compound of the invention solves the problem that the caput femoris vein backflow obstruction causes the increasing of the inner pressure of the caput femoris and has good effect on SANFH caused by other reasons.
Owner:王生

Plaster for treating femoral head necrosis

The invention relates to a plaster for treating femoral head necrosis. Each serving of the plaster for treating avascular necrosis comprises the following raw materials by weight: 7-9g of centipede, 25-30g of lumbricus, 5-10g of long-noded pit viper, 15-20g of baiyao, 25-30g of malt, 15-20g of bighead atractylodes rhizome, 15-20g of borneol, 25-30g of root of three-nerved spicebush, 10-15g of pseudo-ginseng, 5-10g of myrrh, 5-10g of musk and 0.5-0.6kg of liquor. The plaster for treating femoral head necrosis is convenient to use, and has obvious effect.
Owner:谷龙

Method for researching effects of Dickkopf-1 and cell apoptosis in steroid-induced avascular necrosis of femoral head (SANFH)

The invention discloses a method for researching the effects of Dickkopf-1 and cell apoptosis in steroid-induced avascular necrosis of femoral head (SANFH). The method comprises the following steps: by taking the femoral head sample of SANFH taken through total hip replacement as an experiment group and taking the sample after the hip replacement for fracture of neck of femur as a contrast group, cutting the femoral head sample, fixing and decalcifying the cut femoral head sample to prepare slices, observing the morphologic change of osteocytes by an electronic microscope, observing the pathological change of the osteocytes by a light microscope, counting the vacant bone lacuna, detecting the expression of Dickkopf-1 by an immunohistochemical staining technique, thus exploring the effects of Dickkopf-1 and cell apoptosis in SANFH. The method can be used for providing assistance for early diagnosis and curing of SANFH and also providing a theoretical basis for clinical prevention and curing of SANFH in future.
Owner:刘万林

Surgical drawing hook

The invention discloses a surgical drawing hook. The surgical drawing hook comprises a drawing hook (1), a drawing hook connection rod (2) and a hollow cylinder (3), wherein the drawing hook (1) is connected with the drawing hook connection rod (2) through a rubber band (4); scale marks (7) used for marking stress size of the drawing hook are arranged on the drawing hook connection rod (2) along the axis of the drawing hook connection rod (2); a circumferential groove is formed in the end close to one side of the drawing hook connection rod (2) of the drawing hook (1); a through hole matched with the groove is formed in the bottom surface of the cylinder (3); a through hole with the size matched with the size of the drawing hook connection rod (2) is formed in the top surface of the cylinder (3); the through hole in the bottom surface of the cylinder (3) is clamped in the groove; the through hole in the top surface of the cylinder (3) is sleeved on the drawing hook connection rod (2); a handle (6) is arranged at the tail of the drawing hook connection rod (2). The surgical drawing hook is capable of accurately displaying the stress size of the drawing hook so as to avoid the occurrence of situations such as tissue avascular necrosis caused by excessive force of the surgical drawing hook and the like.
Owner:泸州市中医医院

Drug for curing coronary disease

The invention provides a new medicine which has distinguished curative effect and cures coronary heart disease for the market. The invention belongs to the technical field of the Chinese traditional patent medicine. The taking of the medicine is secure, the effect is taken fast, the medicine source is broad, the cost is low, and the production process is simple. The recipe of the invention comprises lycopus herb, cape jasmine, dragon's blood resin, rhubarb, safflower, frankincense, common myrrh tree, red sage root, peach kernel, balloonflower, astragalus root, gleditschia horrida (also honeylocust fruit), rhodiola root, achyranthes root, red peony root, root-bark of peony, forsythia fruit, earth worm and licorice, etc. The pathogenesis of the coronary heart disease comprises blood stasis and blockage. The treatment method comprises blood circulation promotion and blood stasis dissipation, Qi invigoration and blood promotion, and phlegm resolving and orifice opening, namely, the blood is promoted to be smooth in blood vessels. The drugs administration of the recipe of the invention can be ascended or descended, the drug can be used for the cold property and the heat property, the drug has the functions of invigoration as well as the purge, blood circulation promoting as well as blood arresting. The invention is restricted mutually, opposite and united, and accords with the thing development law. The quality of the blood of dragon resin is extremely important. The blood circulation promotion and blood stasis dissipation (comprising blood stasis and phlegm stasis) is a key point. The medicine has the remarkable curative effect to cerebral thrombosis and the traumatic injury, and also has a certain curative effect to the avascular necrosis of femoral head.
Owner:马希文
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products